AllianceBernstein’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-279,400
Closed -$248K 3270
2022
Q4
$248K Hold
279,400
﹤0.01% 2933
2022
Q3
$439K Sell
279,400
-40,700
-13% -$92.3K ﹤0.01% 2712
2022
Q2
$643K Hold
320,100
﹤0.01% 2566
2022
Q1
$746K Buy
320,100
+900
+0.3% +$2.81K ﹤0.01% 2524
2021
Q4
$1.48M Sell
319,200
-100,000
-24% -$621K ﹤0.01% 2296
2021
Q3
$3.2M Buy
419,200
+93,400
+29% +$792K ﹤0.01% 1866
2021
Q2
$3.16M Hold
325,800
﹤0.01% 1904
2021
Q1
$2.69M Buy
325,800
+9,100
+3% +$96.1K ﹤0.01% 1908
2020
Q4
$2.16M Buy
316,700
+2,300
+0.7% +$18.5K ﹤0.01% 1932
2020
Q3
$3.51M Buy
314,400
+55,900
+22% +$512K ﹤0.01% 1545
2020
Q2
$1.62M Sell
258,500
-414,900
-62% -$1.59M ﹤0.01% 1959
2020
Q1
$1.24M Buy
673,400
+400,000
+146% +$1.15M ﹤0.01% 1939
2019
Q4
$924K Buy
273,400
+100,000
+58% +$238K ﹤0.01% 2312
2019
Q3
$371K Buy
173,400
+17,700
+11% +$41.3K ﹤0.01% 2703
2019
Q2
$416K Buy
155,700
+9,700
+7% +$34.9K ﹤0.01% 2696
2019
Q1
$694K Buy
146,000
+25,600
+21% +$67.2K ﹤0.01% 2407
2018
Q4
$289K Buy
120,400
+36,300
+43% +$119K ﹤0.01% 2752
2018
Q3
$370K Buy
84,100
+37,200
+79% +$206K ﹤0.01% 2756
2018
Q2
$338K Buy
+46,900
New +$319K ﹤0.01% 2768
2017
Q2
Sell
-38,800
Closed -$153K 3196
2017
Q1
$153K Hold
38,800
﹤0.01% 2896
2016
Q4
$190K Buy
38,800
+2,900
+8% +$17.4K ﹤0.01% 2902
2016
Q3
$278K Buy
35,900
+4,349
+14% +$29.3K ﹤0.01% 2726
2016
Q2
$177K Buy
31,551
+6,651
+27% +$42.5K ﹤0.01% 2824
2016
Q1
$134K Sell
24,900
-5,100
-17% -$29.6K ﹤0.01% 2789
2015
Q4
$261K Buy
30,000
+3,900
+15% +$32.9K ﹤0.01% 2667
2015
Q3
$219K Buy
26,100
+9,900
+61% +$158K ﹤0.01% 2748
2015
Q2
$285K Buy
+16,200
New +$208K ﹤0.01% 2771

Other funds holding SRNE